CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Last · NYSE$302.00+2.98 (+1.00%)close · yahoo · 10h ago
Vol 941.3K ≈ 284.26M
MA10MA20MA50
Market cap$14.42B47.7M sh
P/E · TTM-62.9fwd 23.7 · eps -4.80 · loss
Beta1.40vs S&P 500
Div yield0.00%annual · TTM
52w range
$146.20$333.30
Volume941.3Ksession
Issuer
Legal nameCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
HQUnited States (US)
ListingUS CRL
ISINUS1598641074
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC8731
CurrencyUSD
Entity registrysec:0001100682
CIK0001100682
Websitewww.criver.com
Employees19,000
AddressCharles River Laboratories International, Inc. 251 Ballardvale Street 01887, Wilmington +781 222 6000
| Revenue | $4.0B |
|---|---|
| Operating income | $25.2M |
| Net income | $-144.3M |
| Free cash flow | $518.5M |
| Operating margin | 0.6% |
| Net margin | -3.6% |
| Return on equity | -4.5% |
| Period | 2025 |
Loading chart…
Upcoming earnings
WED.4NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$2.97
Est. revenue
960.5M
Earnings transcripts
- Motley Fool
Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Issuer webcast
Webcast - Creightons Plc Interim Results 30 September 2024
POTTER & MOORE PLC
- Issuer webcast
Webcast - Creightons Plc Interim Results 30 September 2022
POTTER & MOORE PLC
- Issuer webcast
Webcast - Creightons Plc Interim Results 30 September 2021
POTTER & MOORE PLC
- Issuer webcast
Webcast - Potter & Moore Plc Annual Report and Accounts 2026
POTTER & MOORE PLC
- Issuer webcast
Webcast - Creightons PLC Audited Annual Report and Accounts 2025
POTTER & MOORE PLC